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Abstract
Although murine models for studying the development of cardiac dysfunction in diabetes
mellitus are well established, their reported cardiac phenotypes vary. These reported diver-
gences may, in addition to the severity of different models, also be linked to the methods
used for cardiac functional assessment. In the present study, we examined the functional
changes using conventional transthoracic echocardiography (in vivo) and isolated heart per-
fusion techniques (ex vivo), in hearts from two mouse models; one with an overt type 2 dia-
betes (the db/db mouse) and one with a prediabetic state, where obesity was induced by a
high-fat diet (HFD). Analysis of left ventricular function in the isolated working hearts from
HFD-fed mice, suggested that these hearts develop diastolic dysfunction with preserved
systolic function. Accordingly, in vivo examination demonstrated maintained systolic func-
tion, but we did not find parameters of diastolic function to be altered. In db/db mice, ex vivo
working hearts showed both diastolic and systolic dysfunction. Although in vivo functional
assessment revealed signs of diastolic dysfunction, the hearts did not display reduced sys-
tolic function. The contrasting results between ex vivo and in vivo function could be due to
systemic changes that may sustain in vivo function, or a lack of sensitivity using conven-
tional transthoracic echocardiography. Thus, this study demonstrates that the isolated per-
fused working heart preparation provides unique additional information related to the
development of cardiomyopathy, which might otherwise go unnoticed when only using con-
ventional echocardiographic assessment.
Introduction
The transition to a more sedentary lifestyle and overnutrition, has led to increased incidence
of obesity, hyperglycaemia, insulin resistance, dyslipidaemia, and metabolic syndrome—all
known risk factors of cardiovascular disease. Consequently, cardiovascular disease is the pri-
mary cause of morbidity and mortality in diabetes patients. Diabetes also predisposes to a dis-
tinct cardiomyopathy defined as ventricular dysfunction in the absence of coronary heart
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disease or hypertension [1–3], which leads to the development of diastolic dysfunction prior to
systolic dysfunction and finally heart failure.
A range of murine models is used to elucidate underlying mechanisms in the development
of obesity and diabetes related cardiac dysfunction. Mice homozygous for the obese (Lepob)
and the diabetes (Leprdb) mutations are among the earliest characterized models of obesity-
related insulin resistance and diabetes. In these monogenic models, leptin deficiency (ob/ob
mice) or leptin receptor deficiency (db/db mice) lead to lack of satiety sensation, which conse-
quently causes hyperphagia and hypoactivity. Studies using diabetic db/db mice have reported
both development of ventricular remodelling and cardiac dysfunction [4–8], although there
are studies reporting normal cardiac structure and function [9–11].
Diet-induced obese (DIO) mouse models are currently in extensive use in diabetic cardio-
myopathy research as they recapitulate aspects of the metabolic syndrome associated with
human obesity, and because they are comparable to commonly used genetically modified
models. The reported cardiac phenotype from DIO models range from no change in cardiac
function [12–15] to more severe remodelling and dysfunction [16–19]. Although, these differ-
ences may be linked to the variations between feeding protocols (nutritional composition of
the diet and feeding initiation and duration) and the mouse strain used [20], there is also rea-
son to believe that the techniques and modalities used for cardiac phenotyping influence the
observed functional outcome. Today, assessment of cardiac function in mice primarily
involves different in vivo techniques. The development of high-frequency transducers has
made echocardiography a common modality for cardiac functional assessment of mouse
hearts, and the parameters are mainly derived from M-mode and Doppler imaging. Although
additional parameters from multi-planar images and speckle tracking echocardiography, as
well as other imaging modalities (e.g. magnetic resonance imaging) have become more easily
accessible, conventional echocardiography (M-mode and Doppler imaging) is still the most
widespread in vivo modality [21].
The first reports of cardiac function in mice, published more than 25 years ago, describe
cardiac function using isolated perfused hearts using the working mode [22;23] and the Lan-
gendorff mode [24]. Despite technical challenges due to the small size of the mouse heart, ex
vivo assessment has proven valuable, not only in studying pharmacological effects, but also in
the investigation of disease states and the impact of gene modification in the intact heart. It is
important to emphasize that the ex vivo heart preparation has the advantage of facilitating elu-
cidation of the ventricular performance under defined loading conditions and in the absence
of neurohormonal influences, and may therefore provide unique additional information
related to the development of dysfunction in the myocardium per se.
In the present study, we examined the functional changes in hearts from two mouse models
of obesity/diabetes; the db/db mouse, a model of severe obesity and diabetes, and a DIO model
induced by a high-fat diet, representing a model of obesity and prediabetes. Here, we com-
pared in vivo cardiac function to that obtained ex vivo, using the most used imaging modality
in small animal research (i.e. M-mode echocardiography and Doppler imaging) and isolated
perfused heart techniques, respectively.
Materials and methods
Animals and diet
Mice were purchased from Charles River (Germany). Diet-induced obesity was obtained by
feeding 5-6-week-old male C57BL/6J mice a high-fat diet (HFD) with 60% kcal from fat (lard),
20% kcal from carbohydrates and 20% kcal from protein (58Y1, TestDiet, UK; http://www.
testdiet.com/Diets/High-Fat-DIO/index.html) for 20 weeks. Male diabetic db/db mice
Ex vivo hearts in cardiac phenotyping
PLOS ONE | https://doi.org/10.1371/journal.pone.0204843 October 1, 2018 2 / 18
(C57BL/KsJ-leprdb/leprdb) arrived at an age of 8 weeks and were fed a regular chow diet until
12 weeks of age. We used age-matched mice fed a regular chow diet as controls. All mice were
housed in a room with a constant temperature of 23˚C and 55% humidity, with a 12:12-h
reversed light:dark-cycle. They were given ad libitum access to water and their respective diets
and were treated in accordance with the guidelines on accommodation and care of animals
given by the European Convention for the Protection of Vertebrate Animals for Experimental
and Other Scientific Purposes. The experiments were approved by the local representation of
the National Animal Research Authority in Norway, and carried out in our laboratory at the
University of Tromsø –The Arctic University of Norway.
Blood sampling
Blood was collected from the saphenous vein (14 days prior to sacrificing the animals) after 4
hours of fasting or after a fasting/re-feeding protocol, where the mice were fasted for 3 hours,
and then re-fed for 2 hours. Fasting blood glucose levels were measured using a glucometer
system (FreeStyle Lite, Abbott, Australia), and insulin levels were measured in plasma from
the same blood sample, using a mouse insulin ELISA kit (DRG Instruments GmbH, Ger-
many). Plasma free fatty acids levels were analysed using commercial kits from Wako Chemi-
cals (Neuss, Germany), in plasma collected following fasting/re-feeding.
Echocardiography
Echocardiography was done using the VisualSonics 2100 Vevo Imaging System (Toronto,
Canada) with a 550D probe (frequency of 35–40 MHz) during light isoflurane (1.5–2%) anaes-
thesia. The body temperature was monitored using a rectal thermometer, and maintained at
approximately 37˚C using a heated platform and a heat lamp.
A single operator imaged all mice. Left ventricular (LV) mass, wall thickness, end-systolic
and end-diastolic diameter (LVID;s and LVID;d) and end-systolic and end-diastolic volumes
(ESV and EDV) were determined from parasternal short-axis M-mode images of the midven-
tricle at the level of papillary muscles. The LV mass was calculated from the measured cardiac
borders in diastole, including the interventricular septum (IVS;d), LVID;d and the posterior
wall (LVPW;d), using this formula: LV mass = (1.053((LVID;d+LVPW;d+IVS;d)3-LVID;
d3))0.8. Functional parameters like stroke volume (SV), ejection fraction (EF) and fractional
shortening (FS) were obtained from further calculations of the M-mode data. Ejection fraction
was calculated as EF = (SV/EDV)100 and fractional shortening was calculated from FS =
(LVID;d-LVID;s)/LVID;d100. The ratio between LV Volume and LV mass was used as a
measure of hypertrophy. The early (E) and late/atrial (A) peak ventricular filling velocities, E/
A ratio and deceleration time of early filling (DT) were obtained from transmitral flow, in the
apical 4-chamber view. Early diastolic (E’) and late diastolic (A’) mitral annular myocardial
velocity of the left ventricle septal wall was recorded from the 4-chamber view with pulsed-
wave tissue Doppler. The E/E’ was calculated as an index of LV filling pressure.
Isolated heart perfusions
To evaluate the changes in heart function in the hearts independent of neurohormonal or
loading conditions, we also characterised heart function ex vivo. After an intraperitoneal injec-
tion of pentobarbital, hearts were excised and perfused using a modified Krebs-Henseleit with
added glucose (5mM) and palmitate (0.5 mM) bound to BSA (3%) [25]. Cardiac temperature
was maintained at 37˚C and data were obtained and analysed using LabChart 7Pro software
(ADInstruments, Bella Vista, Australia).
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One group of hearts was perfused in the working heart mode with an 8 mmHg preload and
50 mmHg afterload [25]. Left ventricular pressure changes were assessed using a 1.0-Fr con-
ductance catheter (Millar Instruments, Houston, TX), inserted into the ventricle through the
apex [26]. In another group, the hearts were perfused in the Langendorff mode [27], where left
ventricular pressure was assessed using an intraventricular fluid-filled balloon. The volume of
the balloon was adjusted so that the end-diastolic pressure was between 5–10 mmHg. To pre-
vent build-up of fluid in the ventricle, a cannula (25 G) was inserted through the apex and into
the lumen to allow drainage of fluid [27].
Statistical analysis
The results are presented as means ± SE in tables and column bar graphs. In order to compare
differences between two groups, unpaired Student’s t-tests were performed.
Results
Diet-induced obese mice
5-6-week-old male mice were randomly divided into two groups with similar body weight
(20.7 ± 0.2 g and 20.5 ± 0.2 g). Twenty weeks of feeding with the high-fat diet (HFD) resulted
in obesity as indicated by higher body weight (Fig 1), and a significant increase in perirenal fat
deposits (0.3 ± 0.1 vs 1.0 ± 0.1 g in controls (n = 12) and HFD (n = 13), respectively). Similar
tibia lengths in the two groups of mice supports that the observation of increased weight gain
in HFD mice is attributable to fat deposits and not the animal size per se (Fig 1). In this study,
the HFD mice had elevated fasted blood glucose (p = 0.05, Fig 1), and HOMA-IR values (rep-
resenting insulin resistance) were increased due to a marked increase in fasting insulin levels
(Fig 1). In addition, HFD mice displayed a near 2.4-fold increase in free fatty acids (Fig 1).
In vivo cardiac function. Left ventricular (LV) remodelling and function in vivo, were
assessed using transthoracic echocardiography in anesthetized mice. HFD mice did not show
altered wall thickness, intraventricular diameter or LV mass (Table 1). Fractional shortening
(FS) was increased in the HFD mice, due to a trend towards a decreased LV end-systolic vol-
ume (ESV, p = 0.09, Table 1). There was also a significant increase in stroke volume and ejec-
tion fraction (EF) in HFD mice, but due to a somewhat lower heart rate, cardiac output was
not altered when compared to the age-matched controls (Table 1). Interestingly, the volume-
mass ratio was significantly lower in HFD mice, indicating concentric hypertrophic remodel-
ling (Table 1). Pulsed-wave tissue Doppler showed that the peak velocity of early mitral filling
(E wave—depicting the velocity of blood flow in early ventricular diastolic filling), was not sig-
nificantly altered. However, due to a lowered late mitral filling velocity (A wave—depicting
late ventricular filling), the E/A was unexpectedly augmented in HFD hearts (Table 1). Notably
though, due to the high heart rates in mice, the E and A waves are challenging to consistently
measure [28], and the E/A ratio is not a reliable parameter on its own. E/E’ was unchanged,
while there was a trend towards an elevated mitral valve deceleration time (p = 0.09) in the
HFD mice (Table 1), indicating a mild impairment of diastolic function.
Ex vivo cardiac function. Isolated perfused working hearts from HFD mice showed a
slight but not significant decrease in intrinsic heart rate (p = 0.06, Fig 2). HFD hearts also dis-
played elevated LV end-diastolic pressure (LVEDP) and impaired relaxation as indicated by a
decreased dP/dtmin (p = 0.06) and increased Tau (the relaxation time constant) (Fig 2). On the
other hand, HFD hearts displayed no change in dP/dtmax or cardiac power (the product
between cardiac output and LV developed pressure, Fig 2). Developed pressure (53.0 ± 1.6 vs
52.7 ± 0.9 mmHg in controls (n = 6) and HFD (n = 8), respectively) and cardiac output
Ex vivo hearts in cardiac phenotyping
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Fig 1. Body weight (BW), BW to tibia length (TL) ratio, blood glucose (fasted), plasma insulin (fasted), plasma
free fatty acids (FFA, fasted/re-fed) and insulin resistance (HOMA-IR) from high-fat diet mice (HFD) and age-
matched controls (Con). BW and tibia lengths were obtained from 25–30 mice per group, while blood samples were
obtained from 13 controls and 23 HFD mice. HOMA-IR; Homeostatic Model Assessment—Insulin Resistance. 
p< 0.05 vs Con.
https://doi.org/10.1371/journal.pone.0204843.g001
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(11.3 ± 0.6 vs 10.8 ± 1.1 mL/min in controls (n = 6) and HFD (n = 8), respectively) were not
different from controls either.
The Langendorff perfusion mode has become the most commonly used perfusion mode for
evaluating ex vivo function in mouse hearts, as it less technically challenging when compared
to the working mode. Due to the small size of these hearts, the LV balloon has to be adjusted
after it has been inserted into the LV, and this is generally done so that the LVEDP is between
5–10 mmHg. In this study, the mean values of the control and HFD hearts were 6.9 ± 0.7 and
8.6 ± 0.9 mmHg, respectively. In this perfusion mode, we did not find an increase in dP/dtmin,
which would have indicated impaired relaxation (Table 2). Additionally, none of the parame-
ters of systolic function (maximal systolic pressure, LV developed pressure, dP/dtmax or the
rate-pressure-product) were altered in HFD hearts (Table 2).
db/db mice
12-week-old db/db mice had twice the body weight of the age-matched lean mice (Fig 3). The
db/db animals also displayed a substantial elevation in HOMA-IR level due to a considerable
increase in both fasting insulin and glucose levels. We also found plasma free fatty acids levels
to be significantly increased in the db/db mice (Fig 3).
In vivo cardiac function. Echocardiographic examination revealed elevated LV masses in
db/db mice (Table 3), which is in contrast to previous data obtained by weighing these hearts
[25;29]. This discrepancy may be related to potential differences in myocardial density, which
is not included in the LV mass calculation. There was no change in heart rate between the two
groups, but the db/db hearts showed increased LV diastolic diameter and end-diastolic volume
(EDV, Table 3). As systolic diameter and ESV was unchanged, stroke volume and cardiac out-
put were significantly increased (Table 3). These changes were also associated with a signifi-
cant increase in EF and FS (Table 3). Doppler measurements showed that the E wave was
decreased in db/db hearts (p = 0.003), but since the A wave was also decreased (p = 0.04), the
Table 1. Left ventricular function assessed by transthoracic echocardiography of high-fat diet-fed mice (HFD)
and age-matched controls (Con).
Con (n = 9) HFD (n = 12)
Heart rate (BPM) 452 ± 10 439 ± 9
LVPW;d (mm) 0.79 ± 0.02 0.80 ± 0.01
LVID;d (mm) 4.1 ± 0.1 4.1 ± 0.1
LV mass (mg) 98 ± 3 107 ± 4
LVEDV (μL) 76 ± 3 74 ± 3
LVESV (μL) 36 ± 3 29 ± 2
SV (μL) 41 ± 1 45 ± 2 
EF (%) 54 ± 2 61 ± 2 
FS (%) 28 ± 1 32 ± 1 
Volume/LV mass (μL/mg) 0.78 ± 0.02 0.70 ± 0.02 
E/A 1.4 ± 0.1 1.7 ± 0.1 
E/E’ 32 ± 2 30 ± 1
DT (ms) 25 ± 1 27 ± 1
Data are means ± SE. LVPW;d and LVID;d, left ventricular (LV) posterior wall thickness and internal diameter in
diastole, respectively; EDV and ESV, end-diastolic and end-systolic volumes; SV, stroke volume; EF, ejection
fraction; FS, fractional shortening; E/A; ratio of velocities of early to late ventricular filling, E/E’; ratio of velocity of
early ventricular filling to early diastolic mitral annular velocity, DT; deceleration time.
p < 0.05 vs Con.
https://doi.org/10.1371/journal.pone.0204843.t001
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Fig 2. Left ventricular function assessed in isolated perfused working hearts from high-fat diet fed mice (HFD,
n = 6) and age-matched controls (Con, n = 8). dP/dtmax and dP/dtmin; maximum positive and negative first-time
derivative of left ventricular (LV) pressure respectively, left ventricular end-diastolic pressure (LVEDP), Tau; LV
relaxation time constant calculated by the Weiss method.  p< 0.05 vs Con.
https://doi.org/10.1371/journal.pone.0204843.g002
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E/A remained unchanged (Table 3). Regardless of the unchanged ratio, the lowered filling
velocities might portray increased resistance in the ventricle, and as the db/db hearts also
showed a marked increase in the E/E’ and mitral deceleration time (Table 3), this proves that
these hearts have decreased ventricular compliance and increased myocardial stiffness.
Ex vivo cardiac function. In the isolated working mode, the db/db hearts showed a dia-
stolic dysfunction as indicated by increased LVEDP, lowered dP/dtmin and increased Tau (Fig
4). In addition, a combination of reduced stroke volume (23.8 ± 1.3 vs 14.6 ± 2.7 μL in controls
(n = 10) and db/db (n = 7), respectively) and lowered heart rate (Fig 4), led to a marked
decrease in cardiac output (9.8 ± 0.4 vs 5.1 ± 0.8 mL/min in controls (n = 10) and db/db
(n = 7), respectively). These hearts also showed decreased cardiac power (Fig 4) and finally,
despite the lower HR, a significantly lower LV developed pressure (58.2 ± 1.4 vs 50.7 ± 2.4
mmHg in controls (n = 10) and db/db (n = 7), respectively) and dP/dtmax (Fig 4), which further
supports a decreased systolic function in these hearts. It is, however, important to appreciate
that the impaired cardiac function in these hearts could also be related to the HR.
In Langendorff perfused hearts, the volume of the balloon was adjusted so that the LVEDP
mean values were 6.2 ± 0.6 and 6.7 ± 0.2 mmHg in the control and db/db hearts, respectively.
We did not find dP/dtmin to be altered in the db/db hearts, and neither were parameters of sys-
tolic function (LV developed pressure, rate-pressure-product and dP/dtmax) (Table 4).
Discussion
The present study demonstrates differences between the ex vivo and in vivo cardiac functional
phenotype within the same murine models of diabetes. While isolated perfused working hearts
from diabetic mice showed clear signs of dysfunction, conventional transthoracic echocardiog-
raphy did not reveal this to the same extent. Although lack of in vivo cardiac dysfunction may
be due to a low sensitivity of the M-Mode and Doppler assessment, it may also relate to sys-
temic factors (such as altered neurohormonal status and/or changes in pre- and afterload)
which might mask subtle functional changes in vivo. This study therefore shows how ex vivo
examination can add valuable information when describing the progression of
cardiomyopathy.
The cardiac phenotype in diet-induced obese mice
In accordance with previous studies, mice fed a high-fat diet (HFD) for 20 weeks were in a pre-
diabetic state with obesity, hyperlipidaemia and insulin resistance, but without hyperglycae-
mia. In most studies, long-term high-fat feeding will increase left ventricular (LV) mass and
induce LV concentric hypertrophy [17;30–34]. The reported incidence of systolic and diastolic
Table 2. Left ventricular function assessed in isolated Langendorff perfused hearts from high-fat diet-fed mice
(HFD) and age-matched controls (Con).
Con (n = 12) HFD (n = 12)
Heart rate (BPM) 318 ± 11 307 ± 14
Coronary flow (mL/min) 3.2 ± 0.2 3.4 ± 0.4
Developed pressure (mmHg) 139 ± 8 139 ± 14
dP/dtmax (mmHg/sec) 5282 ± 367 5623 ± 552
dP/dtmin (mmHg/sec) -3610 ± 119 -3654 ± 292
RPP (mmHg x BPM) 44579 ± 3403 42238 ± 4366
Data are means ± SE. dP/dtmax and dP/dtmin; maximum positive and negative first-time derivative of left ventricular
(LV) pressure respectively. RPP; rate-pressure-product (the product of developed pressure and heart rate).
https://doi.org/10.1371/journal.pone.0204843.t002
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Fig 3. Body weight (BW), BW to tibia length (TL) ratio, blood glucose (fasted), plasma insulin (fasted), plasma
free fatty acids (FFA, fasted/re-fed) and insulin resistance from db/db mice and age-matched controls (Con). BW
and tibia lengths were obtained from 25–28 mice per group, while blood samples were obtained from 11 controls and 6
db/db mice. HOMA-IR; Homeostatic Model Assessment—Insulin Resistance.  p< 0.05 vs Con.
https://doi.org/10.1371/journal.pone.0204843.g003
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dysfunction is, however, inconsistent. Systolic dysfunction has been reported following feeding
regimes that varied from 4–6 [33;35] to 15–16 weeks [19;32;36], while the present study and
other studies report no evidence of systolic dysfunction after 20–24 weeks [15;27;31;37;38]. In
general, diastolic dysfunction is considered to advance prior to the development of systolic
dysfunction, and although some studies [17;27;34] support this by showing impaired diastolic
dysfunction without systolic dysfunction, the duration of HFD feeding required to evoke dia-
stolic impairments remains unclear. Additionally, as the functional modalities/techniques
have different sensitivities, lack of reported diastolic dysfunction by one modality/technique,
does not necessarily exclude its occurrence. In accordance with this, a recent study by Schnelle
and colleagues [28] shows how combining several ultrasound-based techniques of diastolic
function (including additional views and speckle tracking echocardiography) will not only
improve the detection of diastolic dysfunction in murine models, but also reveal the underly-
ing pathophysiology for this dysfunction.
The present study showed that while the echocardiographic parameters (obtained by M-
mode and Doppler) did not demonstrate diastolic dysfunction, ex vivo assessment (using per-
fused working hearts) confirmed previous reports of diastolic dysfunction [16;27]. This shows
how ex vivo assessment of function using the working heart mode represents a sensitive and
additional method for evaluation of diastolic dysfunction.
The cardiac phenotype in db/db mice
The db/db mouse represents a type 2 diabetic mouse model, as indicated by obesity, insulin
resistance, hyperglycaemia and hyperlipidaemia. These hearts show an age-dependent increase
in LV mass and wall thickness [5;11;39;40], but the literature is not consistent with regard to
the development of cardiac dysfunction. Semeniuk and colleagues [4] were the first to describe
echocardiographic examination of the db/db mice in 2002, where they reported reduced frac-
tional shortening (FS) and E/A in 12 but not 5-week-old mice. Consistent with this, studies
Table 3. Left ventricular function assessed by transthoracic echocardiography of db/db mice and age-matched
controls (Con).
Con (n = 8) db/db (n = 10)
Heart rate (BPM) 454 ± 10 464 ± 10
LVPW;d (mm) 0.76 ± 0.03 0.81 ± 0.02
LVID;d (mm) 3.83 ± 0.05 4.00 ± 0.04 
LV mass (mg) 86 ± 4 100 ± 3 
LVEDV (μL) 63 ± 2 70 ± 2 
LVESV (μL) 23 ± 2 21 ± 1
SV (μL) 41 ± 2 49 ± 2 
EF (%) 64 ± 2 70 ± 1 
FS (%) 35 ± 2 39 ± 1 
Volume/LV mass (μL/mg) 0.74 ± 0.02 0.71 ± 0.03
E/A 1.6 ± 0.1 1.6 ± 0.1
E/E’ 30 ± 1 41 ± 1 
DT (ms) 26 ± 1 31 ± 2 
Data are means ± SE. LVPW;d and LVID;d, left ventricular (LV) posterior wall thickness and internal diameter in
diastole, respectively; EDV and ESV, end-diastolic and end-systolic volumes; SV, stroke volume; EF, ejection
fraction; FS, fractional shortening; E/A; ratio of velocities of early to late ventricular filling, E/E’; ratio of velocity of
early ventricular filling to early diastolic mitral annular velocity, DT; deceleration time.
p < 0.05 vs Con.
https://doi.org/10.1371/journal.pone.0204843.t003
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Fig 4. Left ventricular function assessed in isolated perfused working hearts from db/db mice (n = 10) and age-
matched controls (Con, n = 7). dP/dtmax and dP/dtmin; maximum positive and negative first-time derivative of left
ventricular (LV) pressure respectively, left ventricular end-diastolic pressure (LVEDP), Tau; LV relaxation time
constant calculated by the Weiss method.  p< 0.05 vs Con.
https://doi.org/10.1371/journal.pone.0204843.g004
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from our laboratory later reported that ex vivo working hearts from 12, but not 5-6-week-old
mice, showed severe dysfunction [25;41–45]. We were therefore surprised to find that echocar-
diographic examination in the present study only revealed a mild diastolic impairment with
no (or even improved) systolic dysfunction. The literature on echocardiographic examination
of db/db mice (14–18 weeks of age), have reported both reduced [8], unaltered [9;11], and
increased systolic function [10]. Although this inconsistency could be due to differences in the
severity of the diabetic phenotype caused by using different background strains in these mice
[46], it may also reflect the lack of sensitivity of conventional echocardiography.
Accordingly, Yue and colleagues [5] reported normal function in young (5-week-old) mice,
but reduced FS and increased end-diastolic volume at an age of 9–13 weeks when using MRI.
Interestingly, despite decreased FS, they found a slight (although not significant) increase in
cardiac output at all ages. Again, the literature is inconsistent, as other studies (using the same
modality) have not reported the same changes [6;47]. It should be noted that Stuckey et al.
reported impairments in contractility and diastolic function in 12-week-old mice when analys-
ing data from high-temporal resolution MRI, despite finding no functional changes when
using standard MRI [6]. Interestingly, maintained systolic function in 12-week-old mice was
supported both by a recent study by Li et al. [48] using both STE and conventional echocardi-
ography. In this study only STE revealed a dysfunction when these mice were 16 weeks old
[48], which suggests that conventional echocardiography lacks the sensitivity to capture subtle
variations in left LV performance.
The very first functional assessment of the db/db hearts was not in vivo but performed using
the isolated perfused working heart. In this study, Belke and colleagues measured intraventric-
ular pressure (using a fluid-filled catheter) and demonstrated a higher end-diastolic pressure,
as well as reduced cardiac output and cardiac power in hearts from 10-14-week-old mice [49].
Impaired ex vivo systolic function was later confirmed in 12-week-old mice [25;41;50]. In
accordance with previous studies [29;44], the present study confirmed both diastolic and sys-
tolic dysfunction, using intraventricular pressure-volume recordings, which allow more accu-
rate assessment of a range of load-dependent and -independent functional parameters.
It should be noted that when these hearts were perfused in the Langendorff mode, there
were no detectable changes in parameters of LV function at neither 12 (present study) nor 24
weeks [47]. Thus, although the Langendorff mode is a suitable ex vivo mode for vascular reac-
tivity studies and acute studies of changes in contractility following drug or ischemic damage,
the present study reinforces that this mode is less suitable for detailed functional assessment,
particularly in models of diastolic dysfunction.
Table 4. Left ventricular function assessed in isolated Langendorff perfused hearts from db/db mice and age-
matched controls (Con).
Con (n = 8) db/db (n = 10)
Heart rate (BPM) 292 ± 26 269 ± 22
Coronary flow (mL/min) 2.7 ± 0.2 2.3 ± 0.2
Developed pressure (mmHg) 133 ± 13 123 ± 8
dP/dtmax (mmHg/sec) 4793 ± 672 4844 ± 446
dP/dtmin (mmHg/sec) -3362 ± 335 -3271 ± 234
RPP (mmHg x BPM) 36778 ± 4954 30683 ± 2690
Data are means ± SE. dP/dtmax and dP/dtmin; maximum positive and negative first-time derivative of left ventricular
(LV) pressure respectively. RPP; rate-pressure-product (the product of developed pressure and heart rate).
https://doi.org/10.1371/journal.pone.0204843.t004
Ex vivo hearts in cardiac phenotyping
PLOS ONE | https://doi.org/10.1371/journal.pone.0204843 October 1, 2018 12 / 18
The cardiac phenotype obtained in vivo vs ex vivo
The functional capacity of the in vivo heart is determined by the endogenous working capacity
of the myocardium, coronary perfusion and changes in systemic factors known to influence
the myocardial function, such as loading conditions and neurohormonal status. Thus, the
functional phenotype of the diabetic heart may be altered due to pathological alterations in the
myocardium itself and/or systemic changes representing compensatory or pathophysiological
alterations.
In the present study, as well as in previous reports, there seems to be a discrepancy between
the in vivo and ex vivo function in db/db hearts, when comparing parameters obtained by con-
ventional echocardiography and the isolated perfused working hearts. As the mechanical func-
tion of the hearts ex vivo is examined under identical loading and neurohormonal conditions,
it could be argued that favourable load-dependent and/or load-independent changes may have
contributed to improve in vivo function. Haemodynamic measurements using LV in vivo cath-
eterization in db/db hearts have supported this notion, first by showing impaired load-indepen-
dent parameters of diastolic dysfunction (increased slope of the end-diastolic pressure-volume
relationship) [5;51–53] and contractility (diminished preload recruitable stroke-work index
and end-systolic elastance) [5;51]. On the other hand, load-dependent parameters of systolic
function (dP/dtmax and cardiac output) were reported to be elevated [50;51], strongly support-
ing changes in the pre- and/or after-load. The increased LVEDP [50–52] and decreased arterial
elastance in these mice [51;53] (both load-dependent parameters), have been argued to signify
increased preload and decreased afterload, respectively [51], further supporting the notion of
compensated haemodynamic conditions in db/db hearts.
Neurohormonal changes (as a compensatory mechanism) may also affect cardiac function
in vivo. Discrepancy between the in vivo and ex vivo heart function has also been reported after
a genetic impairment of SERCA2 function in the heart. While isolated cardiomyocytes from
these hearts showed impaired cell shortening and reduced Ca2+-transient amplitude [54], and
isolated perfused working hearts displayed severe heart failure [55], echocardiographic exami-
nation showed a near normal in vivo function [54]. In support of this, Land et al. [56] demon-
strated, using computational whole-organ simulation, the important role of the compensatory
systemic changes to maintain in vivo function. They showed that the model would only be able
to match the reported in vivo function if they included the effect of β-adrenergic stimulus i.e.
the enhanced Ca2+-transient amplitudes, and increased venous return with its subsequent
Frank-Starling effect [56]. The fact that cardiomyocytes from the db/db hearts also show
impaired SERCA2 function and an accompanying decrease in Ca2+-transient amplitude and
cell shortening [57;58], further supports that compensatory systemic changes can contribute to
sustain in vivo cardiac function in these mice.
As the β-adrenergic drive also influences heart rate (HR), a lower HR in db/db hearts ex
vivo [25;44;50] but not in vivo [39;48;51], supports that the neurohormonal status is altered in
db/db mice. Although we cannot fully exclude that the reduced ex vivo HR in db/db hearts
could have contributed to the reduced function, decreased contractility and impaired relaxa-
tion have also been reported in studies where HR was not significantly different in isolated per-
fused db/db hearts [29;45].
Limitations
The present study, cannot fully exclude the presence of in vivo systolic or diastolic dysfunction.
Here we used the M-mode and Doppler images, as these are the most widely used images, and
are regarded as suitable approaches for assessment of heart disease where the structural
remodelling develop in a uniform manner [21]. It should be noted, however, that a recently
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published guideline for measuring cardiac physiology in mice [21] recommends that detection
of subtle systolic changes requires the use of other imaging modalities or techniques, to give a
comprehensive and full description of cardiac function.
Oxygen delivery/supply can limit the function of an ex vivo heart, as demonstrated by
altered function in rabbit hearts perfused with a buffer that had increased oxygen carrying
capacity [59]. To what extent this also relates to smaller hearts (such as the mouse heart) is not
known, and whether a resulting decrease in myoglobin oxygen saturation will have an impact
on oxidative phosphorylation, remains unresolved [59]. In addition, it is not clear whether the
function of the diabetic heart is more sensitive to mild hypoxia, and thus we do not know to
what extent this may have influenced the systolic dysfunction observed ex vivo, but not in vivo,
in diabetic hearts.
Conclusion
Although continued advances in in vivo imaging will provide access to new and more sensitive
modalities for cardiac phenotyping, this study demonstrates that the isolated heart preparation
remains a valuable tool for assessment of the myocardial function per se, and by that may
bridge in vitro assays and in vivo approaches.
Acknowledgments
The expert technical assistance provided by Trine Lund is gratefully acknowledged. Addition-
ally, the authors would like to thank professor Ajay Shah’s group at the BHF Centre of
Research Excellence, Cardiovascular Division at King’s College London for their advice with
regard to echocardiographic assessments.
Author Contributions
Conceptualization: Tina M. Pedersen, Ellen Aasum.
Formal analysis: Tina M. Pedersen, Neoma T. Boardman, Anne D. Hafstad.
Funding acquisition: Ellen Aasum.
Investigation: Tina M. Pedersen, Neoma T. Boardman, Anne D. Hafstad.
Project administration: Ellen Aasum.
Resources: Ellen Aasum.
Supervision: Ellen Aasum.
Validation: Tina M. Pedersen.
Visualization: Tina M. Pedersen.
Writing – original draft: Tina M. Pedersen.
Writing – review & editing: Tina M. Pedersen, Neoma T. Boardman, Anne D. Hafstad, Ellen
Aasum.
References
1. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR et al. Evidence for Cardio-
myopathy in Familial Diabetes Mellitus. J Clin Invest 1977; 60(4):885–899.
2. Fein FS. Diabetic cardiomyopathy. Diabetes Care 1990; 13(11):1169–79. PMID: 2261838
3. Shehadeh A, Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol 1995; 18(6):301–305.
PMID: 7664503
Ex vivo hearts in cardiac phenotyping
PLOS ONE | https://doi.org/10.1371/journal.pone.0204843 October 1, 2018 14 / 18
4. Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic
db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 2002; 283(3):H976–H982.
https://doi.org/10.1152/ajpheart.00088.2002 PMID: 12181126
5. Yue P, Arai T, Terashima M, Sheikh AY, Cao F, Charo D et al. Magnetic resonance imaging of progres-
sive cardiomyopathic changes in the db/db mouse. American Journal of Physiology-Heart and Circula-
tory Physiology 2007; 292(5):H2106–H2118. https://doi.org/10.1152/ajpheart.00856.2006 PMID:
17122193
6. Stuckey DJ, Carr CA, Tyler DJ, Aasum E, Clarke K. Novel MRI method to detect altered left ventricular
ejection and filling patterns in rodent models of disease. Magn Reson Med 2008; 60(3):582–587.
https://doi.org/10.1002/mrm.21677 PMID: 18727095
7. Plante E, Menaouar A, Danalache BA, Broderick TL, Jankowski M, Gutkowska J. Treatment with brain
natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice. Dia-
betologia 2014; 57(6):1257–1267. https://doi.org/10.1007/s00125-014-3201-4 PMID: 24595856
8. Pei XM, Yung BY, Yip SP, Chan LW, Wong CS, Ying M et al. Protective effects of desacyl ghrelin on
diabetic cardiomyopathy. Acta Diabetologica 2015; 52(2):293–306. https://doi.org/10.1007/s00592-
014-0637-4 PMID: 25192951
9. Daniels A, Van Bilsen M, Janssen BJA, Brouns AE, Cleutjens JPM, Roemen THM et al. Impaired car-
diac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural,
remodelling. Acta Physiologica 2010; 200(1):11–22. https://doi.org/10.1111/j.1748-1716.2010.02102.x
PMID: 20175764
10. Van Bilsen M, Daniels A, Brouwers O, Janssen BJA, Derks WJA, Brouns AE et al. Hypertension Is a
Conditional Factor for the Development of Cardiac Hypertrophy in Type 2 Diabetic Mice. PLOS ONE
2014; 9(1):e85078. https://doi.org/10.1371/journal.pone.0085078 PMID: 24416343
11. Ko KY, Wu YW, Liu CW, Cheng MF, Yen RF, Yang WS. Longitudinal evaluation of myocardial glucose
metabolism and contractile function in obese type 2 diabetic db/db mice using small-animal dynamic
18F-FDG PET and echocardiography. Oncotarget 2017; 8(50):87795–87808. https://doi.org/10.18632/
oncotarget.21202 PMID: 29152121
12. Brainard RE, Watson LJ, DeMartino AM, Brittian KR, Readnower RD, Boakye AA et al. High Fat Feed-
ing in Mice Is Insufficient to Induce Cardiac Dysfunction and Does Not Exacerbate Heart Failure. PLOS
ONE 2013; 8(12):e83174. https://doi.org/10.1371/journal.pone.0083174 PMID: 24367585
13. Dong F, Zhang X, Yang X, Esberg LB, Yang H, Zhang Z et al. Impaired cardiac contractile function in
ventricular myocytes from leptin-deficient ob/ob obese mice. Journal of Endocrinology 2006; 188
(1):25–36. https://doi.org/10.1677/joe.1.06241 PMID: 16394172
14. Zhang L, Ussher JR, Oka T, Cadete VJJ, Wagg C, Lopaschuk GD. Cardiac diacylglycerol accumulation
in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation. Cardiovascular
Research 2011; 89(1):148–156. https://doi.org/10.1093/cvr/cvq266 PMID: 20729341
15. Naresh NK, Butcher JT, Lye RJ, Chen X, Isakson BE, Gan LM et al. Cardiovascular magnetic reso-
nance detects the progression of impaired myocardial perfusion reserve and increased left-ventricular
mass in mice fed a high-fat diet. Journal of Cardiovascular Magnetic Resonance 2016; 18(1):53–63.
https://doi.org/10.1186/s12968-016-0273-y PMID: 27609091
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